Calcipotriene clinical trials
Also written Calcipotriol, Dovonex and Sorilux.
Includes 1 study of Calcipotriene hydrate.
Counted the way a researcher would: Calcipotriene with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses calcipotriene is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the calcipotriene studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 29 Dec 1993 · DOVONEX · NDA 020273 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
69 studies that test it; most in 2013 (8)
| Year | Studies |
|---|---|
| 2004 | 2 |
| 2005 | 6 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 8 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 8 |
| 2018 | 6 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 6 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 38 · Other 32
LEO Pharma (22) · MC2 Therapeutics (5) · Mayne Pharma International Pty Ltd (2) · Derm Research, PLLC (2) · M.D. Anderson Cancer Center (1) · Alexandria University (1) · University of Arizona (1) · Jordan University of Science and Technology (1)
Often tested with
Tested in the same studies.
Betamethasone (35) · Betamethasone dipropionate (26) · Fluorouracil (5) · Tacrolimus (4) · Hydrocortisone (3) · Clobetasol (3) · Apremilast (2) · Tacalcitol (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3
Studies that test calcipotriene.
- Feb 2027Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant RecipientsPhase 2 · University of Arizona
- Mar 2027Comparison of Topical Calcipotriol and Intralesional Steroids in Alopecia AreataPhase 4 · Hayat Abad Medical Complex, Peshawar
- Sep 2027Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCCPhase 1 · Melissa Pugliano-Mauro
Studies
Open first, then newest update. How each study uses calcipotriene is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 70
- A Prospective, Interventional, Exploratory Study Evaluating the Efficacy of Small-Molecule Compound XJH05 Ointment in the Treatment of Plaque PsoriasisRecruitingNot applicableXijing HospitalNCT07780929Written as Calcipotriol ointment
- Comparison of Topical Calcipotriol and Intralesional Steroids in Alopecia AreataNot yet recruitingPhase 4Hayat Abad Medical Complex, PeshawarNCT07453238Written as Calcipotriol
- Utilization of a Microdevice for Psoriasis and Atopic DermatitisNot yet recruitingPhase 4University of California, San FranciscoNCT07352566Written as Calcipotriene
- Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCCRecruitingPhase 1Melissa Pugliano-MauroNCT03370406Written as Calcipotriene
- COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGOEnrolling by invitationEarly Phase 1Dr ayesha wahidNCT06880042Written as Calcipotriol
- Efficacy of Topical 5-Fluorouracil Vs Calcipotriol As Photodynamic Therapy Pre-treatment for Field Actinic KeratosesNot yet recruitingNot applicableSt Vincent's University Hospital, IrelandNCT06685588Written as Calcipotriol
- A Pilot Clinical Trial Comparing Topical Fluorouracil to Fluorouracil Plus Calcipotriene Field Treatments in Patients With Multiple Actinic KeratosesActive, not recruitingPhase 3M.D. Anderson Cancer CenterNCT06851507Written as Fluorouracil/Calcipotriene
- Phototherapy Combination With Topicals in VitiligoCompletedNot applicableJordan University of Science and TechnologyNCT04440371Written as Calcipotriol/Betamethasone ointment plus NBUVB
- A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis SubjectsCompletedPhase 3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07357831Written as MC2-01 cream
- Topical Calcipotriol Versus Photodynamic Therapy in the Treatment of Oral LeukoplakiaActive, not recruitingPhase 2/3Alexandria UniversityNCT07658508Written as Calcipotriol 0.005% gel
- A Study to Investigate Efficacy and Safety With LEO 90100 Compared With Daivobet® Ointment in Adult Chinese Subjects With Stable Plaque PsoriasisCompletedPhase 3LEO PharmaNCT05919082Written as LEO 90100
- Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant RecipientsActive, not recruitingPhase 2University of ArizonaNCT05699603Written as Calcipotriene
- Topical Calcipotriene Treatment for Breast Cancer ImmunopreventionTerminatedPhase 1Massachusetts General HospitalNCT03596073Written as Topical Calcipotriene Ointment
- Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis VulgarisCompletedPhase 2LEO PharmaNCT00817219Written as Calcipotriene plus betamethasone dipropionate ointment
- LEO 90100 Compared to Vehicle in Subjects With Psoriasis VulgarisCompletedPhase 3LEO PharmaNCT01866163Written as LEO 90100
- Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Tacalcitol Ointment and the Gel Vehicle Alone in Patients With Psoriasis VulgarisCompletedPhase 3LEO PharmaNCT00670241Written as calcipotriol and betamethasone (LEO 80185 gel)
- LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)CompletedPhase 3LEO PharmaNCT01188928Written as Calcipotriol plus betamethasone
- Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin FoldsCompletedPhase 3LEO PharmaNCT00691002Written as Calcipotriol plus hydrocortisone (LEO 80190)
- Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque PsoriasisCompletedPhase 2LEO PharmaNCT02387853Written as LEO 90100
- Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin FoldsCompletedPhase 2LEO PharmaNCT00704262Written as Calcipotriol plus hydrocortisone (LEO 80190)
See all 70 studies that test calcipotriene →
Given beside what is tested · 15 — calcipotriene is usual care or a partner of the new treatment
- Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant RecipientsWithdrawnPhase 2Massachusetts General HospitalNCT04642287Written as Calcipotriol Only Product in Cutaneous Dose Form
- A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination ProductsCompletedPhase 2LEO PharmaNCT00875277Written as LEO 29102 Plus Calcipotriol Cream
- LEO19123 Cream in the Treatment of Atopic DermatitisCompletedPhase 2LEO PharmaNCT00392067Written as Calcipotriol and LEO80122 (LEO19123 cream)
- A Psoriasis Plaque Test on LEO 27989 Ointment and Calcipotriol Plus LEO 27989 Ointment in Patients With Psoriasis VulgarisCompletedPhase 1LEO PharmaNCT01297166Written as Calcipotriol plus LEO 27989 ointment
- LEO19123 Cream in the Treatment of Hand EczemaCompletedPhase 2LEO PharmaNCT00404196Written as Calcipotriol and LEO80122 (LEO19123 cream)
- An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis VulgarisCompletedPhase 1LEO PharmaNCT01466478Written as Ointment C: Calcipotriol 50 µg/g ointment
- Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis PatientsCompletedNot applicableGuangdong Provincial Hospital of Traditional Chinese MedicineNCT04275024Written as Calcipotriol ointment
- Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe PsoriasisCompletedPhase 1/2Guangdong Provincial Hospital of Traditional Chinese MedicineNCT03392311Written as Calcipotriol ointment
- A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis VulgarisCompletedPhase 2Eisai LimitedNCT01268527Written as Calcipotriene
- Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque PsoriasisCompletedPhase 1PfizerNCT03469336Written as Calcipotriene/calcipotriol
- Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With CalcipotrieneCompletedPhase 2Sienna BiopharmaceuticalsNCT03448081Written as Calcipotriene
- A 12 Day Study To Evaluate A Topical Drug To Treat Plaque PsoriasisCompletedPhase 1PfizerNCT02193815Written as Daivonex
- Assessing the Efficacy and Safety of Metformin in Treatment of Moderate PsoriasisStatus unknownPhase 3Post Graduate Institute of Medical Education and Research, ChandigarhNCT02644954Written as Topical calcipotriol
- SHP-141C in Plaque Type PsoriasisCompletedPhase 1TetraLogic PharmaceuticalsNCT01646567Written as Calcipotriol
- Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis VulgarisCompletedPhase 1Circassia LimitedNCT01743118Written as Daivonex® ointment
As the comparator · 17 — what is tested is compared with calcipotriene
- Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis.RecruitingPhase 2Mae Fah Luang UniversityNCT07410793Written as Calcipotriol 0.005% ointment
- Comparative Efficacy of Alpha Hydroxy Acids With and Without Nanocarriers Versus Calcipotriol Plus Betamethasone in Treatment of Plaque PsoriasisCompletedNot applicableAl-Azhar UniversityNCT07816575Written as Calcipotriol plus betamethasone
- Efficacy and Safety of LEO 19123 Cream in the Treatment of Psoriasis VulgarisCompletedPhase 2LEO PharmaNCT00764751Written as Dovonex® cream
- Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque TestCompletedPhase 1Boston PharmaceuticalsNCT04221906Written as Daivonex cream (calcipotriol 0.005%)
- Comparison of Indigo Naturalis Oil Extract and Calcipotriol Solution in Treating PsoriasisCompletedPhase 2/3Yin-ku LinNCT01445886Written as Calcipotriol Solution
- Efficacy and Safety of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque PsoriasisCompletedPhase 2Haus BioceuticalsNCT03848806Written as Calcipotriol
- 1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to MapracoratCompletedPhase 1BayerNCT03399526Written as Calcipotriene 0.005% ointment
- Trial to Evaluate Topical C-82 in a Psoriasis Plaque TestCompletedPhase 1/2Prism Pharma Co., Ltd.NCT02432027Written as Daivonex cream
- BAY1003803 Formulation Comparison in Open Psoriasis Plaque TestCompletedPhase 1BayerNCT02940002Written as Betamethasone/calcipotriene
- Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque PsoriasisCompletedPhase 1/2Haus BioceuticalsNCT03069144Written as Calcipotriol
- Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis PatientsCompletedPhase 2Maruho Co., Ltd.NCT01301157Written as Dovonex
- Study to Test the Effectiveness of a New Treatment for Scalp PsoriasisSuspendedPhase 2DermiPsor, Ltd.NCT01368887Written as Calcipotriol Monotherapy
- Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type PsoriasisCompletedPhase 2Deltanoid PharmaceuticalsNCT00625326Written as 50 µg/g Calcipotriene Ointment
- Safety and Efficacy of BFH772 in Psoriasis PatientsCompletedPhase 1/2Novartis PharmaceuticalsNCT00987870Written as calcipotriol/betamethasone
- A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque PsoriasisCompletedPhase 2ZalicusNCT00796211Written as Calcipotriol
- LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque PsoriasisCompletedNot applicableNeoStrata Company, Inc.NCT00705900Written as calcipotriol
- Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque TestCompletedPhase 1/2ISDINNCT00578370Written as 0.005% calcipotriol
Codes
What other systems call calcipotriene · ClinicalTrials.gg INT003366
- MeSH (NLM) C055085calcipotrieneConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 143NQ3779BCALCIPOTRIENEConfirmed FDA, NLM
- RxNorm 29365One source FDA
- NCI Thesaurus C28900CalcipotrieneOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C055085 | calcipotriene | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 143NQ3779B | CALCIPOTRIENE | Confirmed FDA, NLM |
| RxNorm | 29365 | — | One source FDA |
| NCI Thesaurus | C28900 | Calcipotriene | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.